Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Vardenafil: phase III clinical data discussed at congress, trade name selected

Sep. 27, 2002

Trospium meets endpoints in phase III overactive bladder trial

Sep. 25, 2002

Cozaar reduces the risk of ESRD in patients with type 2 diabetes, nephropathy and hypertension

Sep. 23, 2002

New option available for patients with hypertension and diabetic kidney disease

Sep. 20, 2002

Resiniferatoxin: safe and effective for neurogenic and idiopathic bladder overactivity

Sep. 19, 2002

European approval for Fosrenol delayed

Sep. 18, 2002

Research findings support use of KRP-197 for overactive bladder

Sep. 18, 2002

Sustained beneficial effects reported for tadalafil in men with ED

Sep. 18, 2002

Chinese research demonstrates efficacy and safety of epristeride for BPH

Sep. 16, 2002

Pharmacokinetics, efficacy and safety of tadalafil discussed at meeting in Stockholm

Sep. 16, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...